Estimates Revisions Amplia Therapeutics Limited OTC Markets
Stocks
INNM.F
AU0000023822
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0817 USD | -7.16% |
|
-14.00% | +3.55% |
| 05-29 | Amplia Therapeutics Limited Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-28 | Amplia Therapeutics Limited Auditor Raises 'Going Concern' Doubt | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- ATX Stock
- INNM.F Stock
- Consensus Amplia Therapeutics Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
